Hepatitis C virus infection (HCV) represents a unique model to characterize, from early to late stages of infection, the T cell differentiation process leading to exhaustion of human CD8+ T cells. Here we show that in early HCV infection, exhaustion-committed virus-specific CD8+ T cells display a marked upregulation of transcription associated with impaired glycolytic and mitochondrial functions, that are linked to enhanced ataxia-telangiectasia mutated (ATM) and p53 signaling. After evolution to chronic infection, exhaustion of HCV-specific T cell responses is instead characterized by a broad gene downregulation associated with a wide metabolic and anti-viral function impairment, which can be rescued by histone methyltransferase inhibitors. These results have implications not only for treatment of HCV-positive patients not responding to last-generation antivirals, but also for other chronic pathologies associated with T cell dysfunction, including cancer.

Barili V., Fisicaro P., Montanini B., Acerbi G., Filippi A., Forleo G., et al. (2020). Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. NATURE COMMUNICATIONS, 11(1), 1-20 [10.1038/s41467-019-14137-7].

Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection

Ferracin M.;
2020

Abstract

Hepatitis C virus infection (HCV) represents a unique model to characterize, from early to late stages of infection, the T cell differentiation process leading to exhaustion of human CD8+ T cells. Here we show that in early HCV infection, exhaustion-committed virus-specific CD8+ T cells display a marked upregulation of transcription associated with impaired glycolytic and mitochondrial functions, that are linked to enhanced ataxia-telangiectasia mutated (ATM) and p53 signaling. After evolution to chronic infection, exhaustion of HCV-specific T cell responses is instead characterized by a broad gene downregulation associated with a wide metabolic and anti-viral function impairment, which can be rescued by histone methyltransferase inhibitors. These results have implications not only for treatment of HCV-positive patients not responding to last-generation antivirals, but also for other chronic pathologies associated with T cell dysfunction, including cancer.
2020
Barili V., Fisicaro P., Montanini B., Acerbi G., Filippi A., Forleo G., et al. (2020). Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. NATURE COMMUNICATIONS, 11(1), 1-20 [10.1038/s41467-019-14137-7].
Barili V.; Fisicaro P.; Montanini B.; Acerbi G.; Filippi A.; Forleo G.; Romualdi C.; Ferracin M.; Guerrieri F.; Pedrazzi G.; Boni C.; Rossi M.; Vecchi...espandi
File in questo prodotto:
File Dimensione Formato  
2020_Barili-NatComm.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 2.33 MB
Formato Adobe PDF
2.33 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/732445
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 55
social impact